ClinicalTrials.Veeva

Menu
C

Chiang Mai University | Research Institute for Health Sciences

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Doravirine
Rilpivirine
Islatravir
JNJ-53718678

Parent organization

This site is a part of Chiang Mai University

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 9 total trials

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Ages 4 Weeks to <12 Years and <45 kg (MK-1439-066)

This is a single-group, open-label, multi-site study in pediatric participants with human immunodeficiency virus type 1 (HIV-1) infection, aged 4 wee...

Enrolling
Human Immunodeficiency Virus (HIV) Infection
Drug: 2 NRTIs
Drug: Doravirine

The purpose of this study is to evaluate the efficacy, immunogenicity and safety of the 9vHPV vaccine in men 20 to 45 years of age. The primary hypot...

Active, not recruiting
Papillomavirus Infections
Biological: 9vHPV Vaccine
Other: Placebo (Saline for Injection)

This is an open-label study to determine the efficacy, safety, tolerability and immunogenicity of ChAdOx1-HBV and MVA-HBV, together VTP-300, in combi...

Active, not recruiting
Chronic Hepatitis B
Biological: Nivolumab
Biological: ChAdOx1-HBV

Trial sponsors

Merck Sharp & Dohme (MSD) logo
Janssen (J&J Innovative Medicine) logo
Barinthus Biotherapeutics logo
National Institute of Allergy and Infectious Diseases (NIAID) logo
University of Minnesota (UMN) logo
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems